Cargando…
Are the days of closed pleural biopsy over? Yes
In the modern management of pleural diseases, thoracoscopy has a clear advantage over closed pleural biopsy. By way of its high yield, both in malignant pleural disease and pleural Tuberculosis – the two commonest cause of undiagnosed pleural effusion, thoracoscopy has the added advantage of faster...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663875/ https://www.ncbi.nlm.nih.gov/pubmed/26664178 http://dx.doi.org/10.4103/0970-2113.168114 |
_version_ | 1782403379827310592 |
---|---|
author | Patel, Dharmesh |
author_facet | Patel, Dharmesh |
author_sort | Patel, Dharmesh |
collection | PubMed |
description | In the modern management of pleural diseases, thoracoscopy has a clear advantage over closed pleural biopsy. By way of its high yield, both in malignant pleural disease and pleural Tuberculosis – the two commonest cause of undiagnosed pleural effusion, thoracoscopy has the added advantage of faster symptom relief and offering effective pleurodesis. This makes it an attractive diagnostic and therapeutic procedure of choice and features high in the algorithms of many international guidelines on the approach to pleural diseases. |
format | Online Article Text |
id | pubmed-4663875 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-46638752015-12-10 Are the days of closed pleural biopsy over? Yes Patel, Dharmesh Lung India Debates/Point-Counterpoint In the modern management of pleural diseases, thoracoscopy has a clear advantage over closed pleural biopsy. By way of its high yield, both in malignant pleural disease and pleural Tuberculosis – the two commonest cause of undiagnosed pleural effusion, thoracoscopy has the added advantage of faster symptom relief and offering effective pleurodesis. This makes it an attractive diagnostic and therapeutic procedure of choice and features high in the algorithms of many international guidelines on the approach to pleural diseases. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4663875/ /pubmed/26664178 http://dx.doi.org/10.4103/0970-2113.168114 Text en Copyright: © Lung India http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Debates/Point-Counterpoint Patel, Dharmesh Are the days of closed pleural biopsy over? Yes |
title | Are the days of closed pleural biopsy over? Yes |
title_full | Are the days of closed pleural biopsy over? Yes |
title_fullStr | Are the days of closed pleural biopsy over? Yes |
title_full_unstemmed | Are the days of closed pleural biopsy over? Yes |
title_short | Are the days of closed pleural biopsy over? Yes |
title_sort | are the days of closed pleural biopsy over? yes |
topic | Debates/Point-Counterpoint |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663875/ https://www.ncbi.nlm.nih.gov/pubmed/26664178 http://dx.doi.org/10.4103/0970-2113.168114 |
work_keys_str_mv | AT pateldharmesh arethedaysofclosedpleuralbiopsyoveryes |